Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients
- 19 July 2011
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 60 (12) , 1721-1728
Abstract
This study aims to determine whether a semi-quantitative assessment of inflammatory response in tumor and stroma on routine hematoxylin and eosin-stained (H&E) slides can predict survival in patients with epithelioid malignant pleural mesothelioma (MPM). H&E sections of 175 epithelioid MPM specimens from a single institution (1989–2009) were reviewed. Patients who received neoadjuvant chemotherapy were excluded from analysis. Each tumor was histologically assessed for acute and chronic inflammatory response both within the tumor and the stromal component. Inflammatory response was graded: low (none to mild infiltrate) or high (moderate to severe infiltrate). Log-rank test and Cox proportional hazards regression were used to investigate the association between the degree of inflammation (acute/tumor, acute/stroma, chronic/tumor, and chronic/stroma) and overall survival (OS). Patients with high chronic inflammatory response in stroma (n = 59) had improved survival compared to low (n = 116) (median OS = 19.4 vs. 15.0 months, P = 0.01). This prognostic stratification remained significant in stage III patients (median OS = 16.0 vs. 9.3 months, P = 0.03). In multivariate analysis, chronic inflammation in stroma was an independent predictor of survival (HR = 0.659, 95% CI 0.464–0.937, P = 0.02). While high degree of chronic inflammatory cell infiltration in the stromal component was associated with improved overall survival, degree of other inflammatory responses did not show significant correlation with OS. Our study for the first time investigates inflammatory response in tumor and stroma and not only suggests the prognostic value of inflammatory response in epithelioid MPM but also provides rationale for investigation of immunotherapy to benefit epithelioid MPM patients.Keywords
This publication has 27 references indexed in Scilit:
- CCL2 Blockade Augments Cancer ImmunotherapyCancer Research, 2010
- Neutrophil/lymphocyte ratio and its association with survival after complete resection in non–small cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2009
- Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung CancerClinical Cancer Research, 2008
- Regulatory B cells as inhibitors of immune responses and inflammationImmunological Reviews, 2008
- Polarized immune responses differentially regulate cancer developmentImmunological Reviews, 2008
- TUMOR STROMA AND REGULATION OF CANCER DEVELOPMENTAnnual Review of Pathology: Mechanisms of Disease, 2006
- Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinomaBritish Journal of Cancer, 2006
- Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancerJournal of Surgical Oncology, 2005
- The role of tumor stroma in the interaction between tumor and immune systemCurrent Opinion in Immunology, 2005
- No relationship between tumour infiltrating lymphocytes and overall survival is seen in malignant mesothelioma of the pleuraEuropean Journal of Surgical Oncology, 2002